Upload
rosalind-baldwin
View
212
Download
0
Embed Size (px)
Citation preview
FACTORS PREDICTING LARC CONTINUATION IN ADOLESCENT/YOUNG ADULTS VS. ADULT WOMEN
Debbie Postlethwaite RNP, MPHAdekemi Ogultala, MD
Maqdooda Merchant MSc, MA
Presenter Disclosure
Presenter: Debbie Postlethwaite RNP, MPH
No Relationships to Disclose
This study was funded by:
Kaiser Permanente Community Benefits Program
Background Long Acting Reversible Contraception (LARC)
IUC: Levonorgestrel 20 and Copper-T 380 A SCI: Etonogestrel Subdermal Contraceptive Implant
49% of US pregnancies have remained unintended since 19951
Healthy People 2020 goal: 56% planned pregnancies1
IUC: most cost-effective LARC within 12 months of use2
SCI: lowest failure rate (0.05%) within 12 months2,3
ACOG supports the use of LARC in adolescent and young women4
1. U.S. Department of Health and Human Services. Office of Disease Prevention and Health Promotion. Healthy People 2020. Washington, DC. Available at http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=13 (accessed 9/30/2011)
2. Trussell J, Lalla AM, DoanQV, et al. Cost effectiveness of contraceptives in the United States. Contraception, 2009, 79: 5-14.
3. Trussell J. Contraceptive Failures in the United States. Contraception, 2011; 83: 397-404.
4. Long-Acting Reversible Contraception: Implants and Intrauterine Devices . ACOG Practice Bulletin, Clinical Management Guidelines for Obstetricians-Gynecologists, 121; Obstetrics and Gynecology 2011 (118), 1: 184-196.
Research Question
What factors contribute to the 12 month continuation rate of LARC use in adolescents & young adults compared to adult women?
Goal: To gain knowledge about the role that
post-insertion counseling plays, demographic and clinical variables in predicting higher retention/continuation of LARC use in adolescent & young compared to adult women at KPNC.
Methods Study design: Retrospective Cohort study of LARC users between
1/1/2007 to 12/31/2008 with minimum of 12 months membership following LARC insertion
Study subjects: Random proportional stratified sampling of 303 KPNC women with an SCI or IUC insertion; stratified by age: 15-24 vs. 25-34 and by method
Data Collection: Electronic database extraction and detailed medical record review
Variables of interest: Demographic and Clinical: age, race, living situation, and marital status,
Gravidity, Parity, BMI
Reported side effects and complications (< 3, 4-6, 7-12 mo.) Post-insertion counseling (< 3, 4-6, 7-12 mo.) Early LARC removal by time period and reason for removal
Analysis Plan: Descriptive, Chi-square and Fisher Exact tests, Wilcoxon Rank Test, Multtest, and Multivariable logistic regression
Results
* Other: Islander, Native American, Multi-racial
Characteristics Percent (N) Total N = 303
Age 15-24 35.6% (108) 25-34 64.4% (195)
Race Asian 13.5% (41) Black 7.3% (22) Hispanic 33.0% (100)
Other* 4.0% (12)
White 33.3% (101) Missing 8.9% (27)Living Situation/Marital Status Single/Separated/Divorced 37.3% (113) Married/Living with Partner 45.2% (137) Other/Unknown 17.5% (53)Gravidity 0 23.0% (70) 1-2 40.0% (121) 3 19.5% (59) > 4 17.5% (53)
Table 1: Demographic and Clinical Characteristics of LARC Users
Table 1: Demographic and Clinical Characteristics of LARC Users (continued)
Characteristics Percent (N) Total N = 303
Parity 0 28.7% (87)
1-2 53.8% (163)
≥3 17.5% (53)
BMI (Mean) [Median] <Range> (27.3) [26.2] <16.4-56.2> <25 41.9% (127) 25-29.9 30.4% (92) >30 27.7% (84)
LARC Type by Age Group
Cu-T IUC, Age 15-24 6.9% (21)
Cu-T IUC, Age 25-34 26.4% (80)
LNG-IUC, Age 15-24 8.6% (26)
LNG-IUC Age 25-34 24.8% (75)
SCI, Age 15-25 20.1% (61)
SCI, Age 25-34 13.2% (40)
Table 2: Early LARC Removal by Demographic and Clinical CharacteristicsCharacteristics Outcomes
Early LARC Removal
Within 12 Months
No Early LARC Removal
P Value†
Age % (Total N=303) 15-24 23.1% (25) 76.9% (83) 0.52 25-34 20.0% (39) 80.0% (156)Race % (Total N=303)
Asian 17.1% (7) 82.9% (34)
0.82
Black (non-Hispanic) 27.3% (6) 72.7% (16)Hispanic 23.0% (23) 77.0% (77)White (non-Hispanic) 18.8% (19) 81.2% (82)
Other* 23.1% (9) 76.9% (30)Living Situation/Marital Status Single/Separated/Divorced 17.7% (20) 82.3% (93)
0.42Married/Living with Partner 21.9% (30) 78.1% (107)
Other/Unknown 26.4% (14) 73.6% (39)Gravidity % (Total N=303) 0 17.4% (12) 82.6% (57)
0.42 1-2 24.8% (30) 75.2% (91) > 3 19.5% (22) 80.5% (91)Parity % (Total N=303) 0 22.1% (19) 77.9% (67)
0.67 1-2 22.1% (36) 77.9% (127) > 3 16.7% (9) 83.3% (45)BMI % (Total N=303) < 25 18.9% (24) 81.1% 103)
0.72 25-29.9 22.8% (21) 77.1% (71) > 30 22.6% (19) 77.4% (65)
* Other race: Islander, Native American, Multi-racial, missing† P values calculated using Chi-Square tests
Early Removal by LARC Type and Age
Characteristics Outcomes
Early Removal
No Early Removal
P value*
LARC Type by Age CategorySCI, Age 15-24 27.9% (17) 72.1% (44) 0.45SCI, Age 25-34 35.0% (14) 65.0% (26)Cu-T IUC, Age 15-24 19.0% (4) 81.0% (17) 0.75Cu-T IUC, Age 25-34 16.2% (13) 83.8% (67)LNG IUC, Age 15-24 15.4% (4) 84.6% (22) 1.00LNG IUC, Age 25-34 16.0% (12) 84.0% (63)IUC: Cu-T vs. LNCCu-T 16.8% (17) 83.2% (84) 0.85LNG 15.8% (16) 84.2% (85)LARC: IUC vs. LARCAny IUC 16.3% (33) 83.7% (169) 0.004
SCI 30.7% (31) 69.3% (70)
* P values calculated using Chi-Square tests
Early LARC Removal by Reported Complaints
Characteristic Outcome
Early Removal
No Early Removal
P value*
Reported Complaints
Bleeding/Any Time Period 35.5% (33) 64.5% (60) <0.0001
Pain/ Any Time Period 34.0% (16) 66.0% (31) 0.02
Amenorrhea/Any Time Period 26.7% (8) 73.3% (22) 0.43
Other†/Any Time period 33.3% (30) 66.7% (60) 0.0007
Reported Bleeding Complaints by Time Period
< 3 months 33.3% (21) 66.7% (42) 0.008
4 - 6 months 33.3% (5) 66.7% (10) 0.32‡
7-12 months 48.4% (15) 51.6% (16) <0.001
* P values calculated using Chi-Square tests† Other complaints included: headaches, weight gain, mood changes or depression ‡ P value calculated using Fisher Exact test
Reported Complaints, Retention Counseling and Early LARC Removal
* Complaints included: unscheduled bleeding, amenorrhea, pelvic or LARC insertion site pain, headaches, weight gain, depression or mood changes† Outcome timeframes: < 3 months, 4-6 months, 7-12 months after LARC insertion
Complaints and Counseling Age Category P value*
Age: 15-24 Age: 25-34
Any Complaint†, Any Timeframe‡; % (N)
57.4% (62) 58.5% (114) 0.86
Retention Counseling, Any Timeframe‡ % (N)
40.7% (44) 43.1% (84) 0.69
There were no statistical differences in early LARC removal among women with complaints + retention counseling (N=114) by:• Age (15-24: 28.9% vs. 25-34: 22.4%; p=0.44)• LARC type (Cu-T IUC: 20.7%, LNG-IUC: 22.0%, SCI: 31.4%; p=0.52)• BMI (<25: 17.0% , 25-29: 34.2%, > 30: 24.1%; p=0.19)
Predictors of Early SCI Removal
Predictive Characteristics Odds* Ratio
Confidence Interval
P value*
Age (categorical) 15-24 vs. 25-34
1.01 0.51 – 1.99 0.99
Cu-T IUC vs. SCI 0.38 0.17 – 0.84 < 0.02
LNG IUC vs. SCI 0.28 0.12 – 0.63 < 0.002
BMI < 25 vs. > 25 0.58 0.31 – 1.098 0.10
Any Reported Bleeding 2.95 1.62 – 5.37 0.004
Any Reported Pain 3.09 1.41 – 6.76 0.005
* ORs, Confidence Intervals and P-values calculated with logistic regression
Strengths and Limitations Strengths:
Large cohort of adolescent, young adult and adult LARC users with diverse demographic and clinical characteristics
KPNC Integrated electronic medical records and databases
Documentation of clinical visits, phone visits and secure e-mail exchanges between patient and healthcare provider
Limitations Integrated Health Care System (public or privately insured) population
limiting generalizability
Retrospective study design
Limited documentation of LARC retention counseling encounters
Conclusion Reported side effects (bleeding, pain) were strong predictors of
early LARC removal, regardless of method type or age group of user
Post-insertion counseling did not significantly affect LARC continuation regardless of age group or method type
IUC use, compared to SCI use, had higher continuation rates in
both adolescent/young and adult women
LARC methods appeared to be as acceptable to adolescent/young women as they were to adult women
LARC methods have potential to reduce unintended US pregnancies